Markets:

Overview

News

Currencies

International

Treasuries

Intercept Pharmaceuticals, Inc. - Common Stock (NQ:ICPT)

N/A UNCHANGED

Last Price Updated: 4:00 PM EST, Nov 7, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Intercept Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

NGM Biopharma to Release Mid-Stage NASH Data Monday: What to Expect? ↗

May 24, 2021

NGM Biopharmaceuticals, Inc. (NASDAQ: NGM) is a clinical-stage biopharma developing liver and metabolic disorders therapies. Its stock is down just 6.2% year-to-date...

Via Benzinga

Hidden Gem Report: Intercept Pharma Ready To Explode ↗

May 18, 2021

This biotech company is flying under the radar and could see easily 100% upside in the near-term based on both fundamental and technical signals.

Via Talk Markets

Stocks That Hit 52-Week Lows On Tuesday ↗

May 11, 2021

Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW...

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗

May 12, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...

Via Benzinga

The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings ↗

May 11, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...

Via Benzinga

The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs ↗

May 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:...

Via Benzinga

Intercept Pharmaceuticals Inc (ICPT) Q1 2021 Earnings Call Transcript ↗

May 07, 2021

ICPT earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Earnings Preview: Intercept Pharmaceuticals ↗

May 05, 2021

Intercept Pharmaceuticals (NASDAQ:ICPT) unveils its next round of earnings this Thursday, May 06. Here is Benzinga's everything-that-matters guide for the earnings announcement....

Via Benzinga

With Important Trial Results Due in June, Is This Drugmaker a Good Buy Now? ↗

April 23, 2021

The company faced challenges last year in expanding the label of its only drug. Will 2021 bring different results?

Via The Motley Fool

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Intercept Pharmaceuticals, Inc. - Common Stock (NQ:ICPT)

Headline News about Intercept Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today